Posted by Michael Wonder on 08 Nov 2023
MHRA authorises enzyme inhibitor anastrozole to prevent breast cancer in post-menopausal women
6 November 2023 - Anastrozole is now authorised as a preventative treatment for post-menopausal women at moderate or high risk of breast cancer.
Anastrozole was already authorised for use in the treatment of breast cancer in post-menopausal women and has been used off-label for prevention.
